دكتر عطايي

Download Report

Transcript دكتر عطايي

Sexually Transmitted Infections
ATAEI .B , MD. MPH.
‫‪CASE 1‬‬
‫‪ ‬مرد جوانی ‪ 4‬روز بعد از تماس جنسی مشکوک دچار ضایعه‬
‫دردناک الت تناسلی می شود د‪ .‬در معاینه زخم نمای کثیف‬
‫دارد وبه اسانی خونریزی می نماید‪ .‬ودر لمس سفتی ندارد‪.‬‬
‫غده لنفاوی بزرگ و دردناک نیز در ناحیه اینگوینال لمس‬
‫میگردد‪.‬‬
‫‪ ‬تشخیص بالینی شما چیست؟‬
ETIOLOGY
 Usual
causes
 Herpes simplex virus (HSV)
 Haemophilus
ducreyi (chancroid)
USUAL INITIAL LABORATORY EVALUATION



culture, direct FA, ELISA, or PCR for HSV;
consider HSV-2-specific serology.
In chancroid-endemic area:
PCR or culture for H. ducreyi
INITIAL TREATMENT
Herpes confirmed or suspected (history or
sign of vesicles):
 Treat for genital herpes with :

 acyclovir,
valacyclovir, or famciclovir
INITIAL TREATMENT
First episodes:
 acyclovir (200 mg 5 times per day or 400 mg
tid),
 valacyclovir (1 g bid),
 famciclovir (250 mg bid) for 7–14 days is
effective.

INITIAL TREATMENT
Symptomatic recurrent genital herpes:
 Short-course (1- to 3-day) regimens are
preferred because of low cost and
convenience.
 Oral acyclovir (800 mg tid for 2 days),
valacyclovir (500 mg bid for 3 days), or
famciclovir (750 or 1000 mg bid for 1 day,

INITIAL TREATMENT

Chancroid confirmed or suspected
(diagnostic test positive, or HSV and syphilis
excluded, and lesion persists):
Ciprofloxacin 500 mg PO as single dose or
 Ceftriaxone 250 mg IM as single dose or
 Azithromycin 1 g PO as single dose

‫‪CASE 2‬‬
‫‪ ‬بیمار ‪ 30‬ساله ای ‪3‬هفته بعد از یک تماس جنسی مشکوک‬
‫دچار یک پاپول روی دستگاه تناسلی شده است این ضایعه ‪3‬‬
‫روز بعد تبدیل به اولسر با جدار منظم می شود که بدون درد‬
‫ودر معاینه سفت است وهمراه با لنفادنوپاتی بدون درد یکطرفه‬
‫میباشد‪.‬‬
‫‪ ‬تشخیص بالینی شما چیست؟‬
ETIOLOGY
 Usual
causes
Treponema pallidum (primary syphilis)
 lymphogranuloma venereum

USUAL INITIAL LABORATORY EVALUATION
Dark-field exam,
 direct FA,
 PCR for T. pallidum;
 RPR or VDRL test for syphilis (if negative but
primary syphilis suspected, repeat in 1
week);

INITIAL TREATMENT

Syphilis confirmed (dark-field, FA, or PCR
showing T. pallidum, or RPR reactive):
Benzathine penicillin 2.4 million units IM
once to patient,
 Preventive treatment
 Recent (e.g., within 3 months)
 Seronegative partner(s),
 All seropositive partners

MANAGEMENT OF SYPHILIS IN PREGNANCY
Every pregnant woman should undergo a
nontreponemal test at her first prenatal
visit
 If at high risk of exposure, again in the
third trimester and at delivery.


In the untreated pregnant patient with
presumed syphilis, expeditious treatment
appropriate to the stage of the disease is
essential.
RECOMMENDED FOLLOW-UP EVALUATION AFTER THERAPY FOR
SYPHILIS
Stage of Syphilis
Tests to Perform
When to Perform
Re-Treatmenta
Considered If:
Primary or
secondary
Quantitative RPR
or VDRL
HIV-uninfected: 6
and 12 months
HIV-infected: 3, 6,
9, 12, and 24
months
1. Titer increases
by fourfold or
2. Titer fails to
decline by fourfold
or test fails to
become
nonreactive by 6
months or
3. Clinical signs
persist or recur
‫‪CASE 3‬‬
‫‪ ‬جوان ‪ 23‬ساله ای ‪ 4‬روز بعد از تماس جنسی مشکوک‬
‫به علت ترشح از مجرا و سوزش ادرار به مطب شما‬
‫مراجعه می نماید‪.‬‬
‫‪ ‬تشخیص بالینی شما چیست؟‬
URETHRITIS

(1) mucopurulent or purulent urethral
discharge,

(2) Gram stain of urethral secretions
demonstrating 5 or more leukocytes per oil
immersion microscopic field, or
URETHRITIS

(3) a positive leukocyte esterase test on
first-void urine or microscopic
examination of first-void urine
demonstrating 10 or more leukocytes per
high-power field.
ETIOLOGY

Neisseria gonorrhoeae*

CAUSES OF NONGONOCOCCAL URETHRITIS

Chlamydia trachomatis (15–50%)*
Ureaplasma urealyticum (10–40%)*
Mycoplasma genitalium (30%??)
Trichomonas vaginalis (1–17%)*
Herpes simplex virus (primary) (?%)




TREATMENT
Initial Treatment for Patient and Partners
Treat gonorrhea (unless
excluded):
plus
Treat chlamydial infection:
Ceftriaxone, 125 mg IM; or
Azithromycin, 1 g PO; or
Cefpodoxime, 400 mg PO; or
Doxycycline, 100 mg bid for 7
days
Cefixime, 400 mg PO
*Epidemiologic treatment of sexual partners is recommended
ALTERNATIVE REGIMENS

Ceftizoxime (500 mg IM, single dose)
or

Cefotaxime (500 mg IM, single dose)
or

Spectinomycin (2 g IM, single dose)
or

Cefotetan (1 g IM, single dose) plus probenecid (1
g PO, single dose)
or

Cefoxitin (2 g IM, single dose) plus probenecid (1 g
PO, single dose)